The Impact of the 13-Valent Pneumococcal Conjugate Vaccine on Otitis Media-Related Antibiotic Use Among Young Children in Tennessee, USA

被引:4
作者
Griffith, Hannah [1 ]
Wiese, Andrew D. [1 ]
Mitchel, Edward F., Jr. [1 ]
Grijalva, Carlos G. [1 ,2 ]
机构
[1] Vanderbilt Univ, Dept Hlth Policy, Med Ctr, Nashville, TN USA
[2] Vet Affairs Tennessee Valley Hlth Care Syst, Nashville, TN USA
基金
美国国家卫生研究院;
关键词
otitis media; antibiotic use; pneumococcal conjugate vaccines; HEALTH-CARE UTILIZATION; ANTIMICROBIAL RESISTANCE; CHILDHOOD IMMUNIZATION; PNEUMONIA; HOSPITALIZATIONS; ADMISSIONS; DIAGNOSIS;
D O I
10.1093/ofid/ofac019
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Otitis media (OM) is a leading cause of pediatric antibiotic use. Introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) led to reductions in OM among US children, though its impact on OM-related antibiotic use remains unclear. Among 499 683 Tennessee children <2 years of age, the OM-related antibiotic fill rate was stable after PCV13 introduction.
引用
收藏
页数:4
相关论文
共 28 条
[1]   Ten year public health impact of 13-valent pneumococcal conjugate vaccination in infants: A modelling analysis [J].
Chapman, Ruth ;
Sutton, Kelly ;
Dillon-Murphy, Desmond ;
Patel, Shreeya ;
Hilton, Betsy ;
Farkouh, Ray ;
Wasserman, Matt .
VACCINE, 2020, 38 (45) :7138-7145
[2]   Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis [J].
Costelloe, Ceire ;
Metcalfe, Chris ;
Lovering, Andrew ;
Mant, David ;
Hay, Alastair D. .
BMJ-BRITISH MEDICAL JOURNAL, 2010, 340 :1120
[3]   Effectiveness of the 7-and 13-Valent Pneumococcal Conjugate Vaccines Against Vaccine-Serotype Otitis Media [J].
Dagan, Ron ;
van der Beek, Bart Adriaan ;
Ben-Shimol, Shalom ;
Pilishvili, Tamara ;
Givon-Lavi, Noga .
CLINICAL INFECTIOUS DISEASES, 2021, 73 (04) :650-658
[4]   Long-term prognosis of acute otitis media in infancy: determinants of recurrent acute otitis media and persistent middle ear effusion [J].
Damoiseaux, RAMJ ;
Rovers, MM ;
Van Balen, FAM ;
Hoes, AW ;
de Melker, RA .
FAMILY PRACTICE, 2006, 23 (01) :40-45
[5]   Pneumococcal conjugate vaccines for preventing acute otitis media in children [J].
de Sevaux, Joline L. H. ;
Venekamp, Roderick P. ;
Lutje, Vittoria ;
Hak, Eelko ;
Schilder, Anne G. M. ;
Sanders, Elisabeth A. M. ;
Damoiseaux, Roger A. M. J. .
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020, (11)
[6]   The effect of pneumococcal conjugate vaccines on otitis media from 2005 to 2013 in children aged ≤5 years: a retrospective cohort study in two Swedish regions [J].
Edmondson-Jones, Mark ;
Dibbern, Therese ;
Hultberg, Marcus ;
Anell, Bengt ;
Medin, Emma ;
Feng, Yang ;
Talarico, Carla .
HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2021, 17 (02) :517-526
[7]  
Griffin MR, 2014, MMWR-MORBID MORTAL W, V63, P995
[8]   US Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination [J].
Griffin, Marie R. ;
Zhu, Yuwei ;
Moore, Matthew R. ;
Whitney, Cynthia G. ;
Grijalva, Carlos G. .
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (02) :155-163
[9]   Population-based impact of routine infant immunization with pneumococcal conjugate vaccine in the USA [J].
Grijalva, Carlos G. ;
Griffin, Marie R. .
EXPERT REVIEW OF VACCINES, 2008, 7 (01) :83-95
[10]   Decline in pneumonia admissions after routine childhood immunisation with pneumococcal conjugate vaccine in the USA: a time-series analysis [J].
Grijalva, Carlos G. ;
Nuorti, J. Pekka ;
Arbogast, Patrick G. ;
Martin, Stacey W. ;
Edwards, Kathryn M. ;
Griffin, Marie R. .
LANCET, 2007, 369 (9568) :1179-1186